세계의 실사용증거(RWE) 솔루션 시장 보고서(2025년)

Real-world evidence (RWE) refers to clinical insights obtained from data collected outside of controlled clinical trials. This data can come from various sources, including electronic health records, insurance claims, and patient registries. RWE is valuable for evaluating the safety, effectiveness, and usage of medical treatments in real-world healthcare settings.

Key components of real-world evidence solutions include services, data sets, clinical setting data, claims data, pharmacy data, and patient-powered data. Services encompass activities or tasks performed with a commercial purpose and find application in various therapeutic areas such as oncology, cardiovascular disease, neurology, immunology, and others. These solutions are employed in critical processes such as drug development and approval, medical device development and approval, reimbursement/coverage and regulatory decision-making, as well as post-market safety and adverse event monitoring. End-users of real-world evidence solutions include pharmaceutical and medical device companies, healthcare providers, healthcare payers, and other entities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The real world evidence solutions market research report is one of a series of new reports from The Business Research Company that provides real world evidence solutions market statistics, including real world evidence solutions industry global market size, regional shares, competitors with a real world evidence solutions market share, detailed real world evidence solutions market segments, market trends and opportunities, and any further data you may need to thrive in the real world evidence solutions industry. This real-world evidence solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The real world evidence solutions market size has grown rapidly in recent years. It will grow from $2.03 billion in 2024 to $2.33 billion in 2025 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to growth in pharmaceutical and healthcare sectors, demand for post-market surveillance and drug safety, expansion of electronic health records and data, adoption in clinical research and outcomes assessment, regulatory standards for real-world evidence (rwe).

The real world evidence solutions market size is expected to see rapid growth in the next few years. It will grow to $4.18 billion in 2029 at a compound annual growth rate (CAGR) of 15.7%. The growth in the forecast period can be attributed to customized rwe solutions for specificTherapeutic areas, expansion of real-world data networks, innovation in real-world evidence generation, adoption of rwe in drug development and access, collaboration between healthcare and technology sectors. Major trends in the forecast period include ai-driven predictive analytics in rwe, regulatory compliance in rwe data privacy and security, personalized rwe solutions for healthcare providers, transparency in data sharing and rwe findings, integration of rwe in drug pricing and reimbursement.

The forecast of 15.7% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. health analytics by increasing costs for Artificial intelligence-powered patient data aggregation platforms developed in Israel and Estonia, potentially compromising post-market surveillance and raising pharmacovigilance expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing geriatric population is anticipated to drive the growth of the real-world evidence solutions market. The geriatric population, defined as individuals aged 65 and older, is at a higher risk for various issues, including postural hypotension and balance or gait impairments. Aging also heightens the risk of chronic diseases such as strokes, cardiovascular conditions, type 2 diabetes, arthritis, and cancer. For instance, data published by the Population Reference Bureau, a nonprofit organization based in the U.S., indicates that the population of Americans aged 65 and older is projected to rise from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Furthermore, their proportion of the total population is expected to grow from 17% to 23%. Consequently, the expanding geriatric population is a key driver of the real-world evidence solutions market.

Government support is poised to play a crucial role in propelling the growth of the real-world evidence solutions market in the future. Increased government initiatives aimed at enhancing public awareness and understanding of real-world evidence solutions have a positive impact on the overall market expansion. Government backing creates a conducive environment for the adoption and growth of real-world evidence solutions in the healthcare industry. This support empowers healthcare providers and pharmaceutical companies to make more informed decisions concerning patient care and drug development. Notably, in February 2023, the UK government pledged increased investment with a specific focus on entities responsible for approving medical devices and ensuring compliance with new regulatory requirements. Additionally, the Romanian government, in June 2022, launched the National Agency for Health Infrastructure Development to bring more coherence to investments in health infrastructure. Thus, government support is expected to contribute significantly to the growth of the real-world evidence solutions market.

The advancement of real-world evidence has emerged as a significant trend in the real-world evidence market. The ability to achieve commercial success and facilitate informed decision-making through real-world data is increasingly important, and real-world evidence effectively meets the demand for additional insights. For example, in May 2023, Inspire, a data infrastructure and analytics company based in the U.S., introduced its Real-World Evidence (RWE) solutions. Inspire RWE provides innovative data and analytics tools for life sciences companies, utilizing its patient engagement platform to collect real-world insights from millions of patients, with the goal of enhancing patient-centered healthcare outcomes.

Major companies in the real-world evidence solutions market are actively developing innovative products, such as the introduction of a new Real-World Evidence (RWE) Solutions service designed to optimize evidence-based medicine. Real-World Evidence Solutions services aim to generate and analyze clinical evidence on the usage, potential benefits, and risks of medical products using real-world data (RWD) derived from routine healthcare delivery. For instance, in October 2023, Maxis Clinical Sciences launched a new Real-World Evidence (RWE) Solutions service, combining various RWD sources, including patient-reported outcomes and data from wearable devices, to enhance patient participation and data quality.

In October 2022, Cegedim SA, a software company based in France, acquired Clinityx for an undisclosed amount. This acquisition bolsters Cegedim's Real-World Data portfolio, furthering its objective to become a leader in Europe's real-world health data market by enhancing its data-driven healthcare solutions. Clinityx, also based in France, specializes in health data and real-world data solutions.

Major companies operating in the real world evidence solutions market include Anthem Inc., Cegedim Health Data, Clarivate PLC, Clinigen Group, Cognizant Technology Solutions Corporation, Flatiron Health Inc., International Business Machines Corporation, ICON plc, IQVIA Holdings Inc., Medpace Holdings Inc., Optum Inc., Oracle Corporation, PAREXEL International Corporation, PerkinElmer Inc., PPD Inc., SAS Institute Inc., Syneos Health, Symphony Innovation LLC, UnitedHealth Group Incorporated, Amerisource Bergen Corporation, Cardinal Health, Deloitte Touche Tohmatsu Limited, Informa PLC, Palantir Technologies, UDG Healthcare PLC, Thermo Fisher Scientific Inc., Elevance Health Inc., Covance Consulting Ltd., Clinipace Worldwide, Evidera Inc., Pharmerit International, Analysis Group Inc., HealthCore Inc., Inovalon Holdings Inc., KMK Consulting Inc.

North America was the largest region in the real world evidence solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the real world evidence solutions market share during the forecast period. The regions covered in the real-world evidence solutions market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the real-world evidence solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The real-world evidence solutions market consists of sales of solutions that are used in randomized trials, large simple trials, pragmatic trials, and observational studies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Real World Evidence Solutions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on real world evidence solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for real world evidence solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The real world evidence solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: Services; Data Sets; Clinical Setting Data; Claims Data; Pharmacy Data; Patient Powered Data
• 2) By Therapeutic Area: Oncology; Cardiovascular; Neurology; Immunology; Other Therapeutic Areas
• 3) By Application: Drug Development And Approvals; Medical Device Development And Approvals; Reimbursement/Coverage And Regulatory Decision Making; Post Market Safety And Adverse Events Monitoring
• 4) By End-Users: Pharmaceutical And Medical Devices Companies; Healthcare Providers; Healthcare Payers; Other End-Users
• Subsegments:
• 1) By Services: Consulting Services; Data Management Services; Regulatory Services; Analytics Services
• 2) By Data Sets: Electronic Health Records (EHR); Patient Registries; Clinical Trials Data; Observational Study Data
• 3) By Clinical Setting Data: Hospital Data; Outpatient Data; Specialty Care Data; Claims Data
• 4) By Insurance Claims Data: Medicare/Medicaid Data; Commercial Claims Data; Pharmacy Data
• 5) By Prescription Data: Pharmacy Claims Data; Drug Utilization Data
• 6) By Patient Powered Data: Patient Surveys; Patient-Reported Outcomes (PRO); Wearable Device Data
• Companies Mentioned: Anthem Inc.; Cegedim Health Data; Clarivate PLC; Clinigen Group; Cognizant Technology Solutions Corporation; Flatiron Health Inc.; International Business Machines Corporation; ICON plc; IQVIA Holdings Inc.; Medpace Holdings Inc.; Optum Inc.; Oracle Corporation; PAREXEL International Corporation; PerkinElmer Inc.; PPD Inc.; SAS Institute Inc.; Syneos Health; Symphony Innovation LLC; UnitedHealth Group Incorporated; Amerisource Bergen Corporation; Cardinal Health; Deloitte Touche Tohmatsu Limited; Informa PLC; Palantir Technologies; UDG Healthcare PLC; Thermo Fisher Scientific Inc.; Elevance Health Inc.; Covance Consulting Ltd.; Clinipace Worldwide; Evidera Inc.; Pharmerit International; Analysis Group Inc.; HealthCore Inc.; Inovalon Holdings Inc.; KMK Consulting Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Real World Evidence Solutions Market Characteristics

3. Real World Evidence Solutions Market Trends And Strategies

4. Real World Evidence Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Real World Evidence Solutions Growth Analysis And Strategic Analysis Framework

• 5.1. Global Real World Evidence Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Real World Evidence Solutions Market Growth Rate Analysis
• 5.4. Global Real World Evidence Solutions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Real World Evidence Solutions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Real World Evidence Solutions Total Addressable Market (TAM)

6. Real World Evidence Solutions Market Segmentation

• 6.1. Global Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Services
• Data Sets
• Clinical Setting Data
• Claims Data
• Pharmacy Data
• Patient Powered Data
• 6.2. Global Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Cardiovascular
• Neurology
• Immunology
• Other Therapeutic Areas
• 6.3. Global Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Development And Approvals
• Medical Device Development And Approvals
• Reimbursement/Coverage And Regulatory Decision Making
• Post Market Safety And Adverse Events Monitoring
• 6.4. Global Real World Evidence Solutions Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Medical Devices Companies
• Healthcare Providers
• Healthcare Payers
• Other End-Users
• 6.5. Global Real World Evidence Solutions Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consulting Services
• Data Management Services
• Regulatory Services
• Analytics Services
• 6.6. Global Real World Evidence Solutions Market, Sub-Segmentation Of Data Sets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Electronic Health Records (EHR)
• Patient Registries
• Clinical Trials Data
• Observational Study Data
• 6.7. Global Real World Evidence Solutions Market, Sub-Segmentation Of Clinical Setting Data, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Data
• Outpatient Data
• Specialty Care Data
• Claims Data
• 6.8. Global Real World Evidence Solutions Market, Sub-Segmentation Of Insurance Claims Data, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medicare/Medicaid Data
• Commercial Claims Data
• Pharmacy Data
• 6.9. Global Real World Evidence Solutions Market, Sub-Segmentation Of Prescription Data, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmacy Claims Data
• Drug Utilization Data
• 6.10. Global Real World Evidence Solutions Market, Sub-Segmentation Of Patient Powered Data, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Patient Surveys
• Patient-Reported Outcomes (PRO)
• Wearable Device Data

7. Real World Evidence Solutions Market Regional And Country Analysis

• 7.1. Global Real World Evidence Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Real World Evidence Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Real World Evidence Solutions Market

• 8.1. Asia-Pacific Real World Evidence Solutions Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Real World Evidence Solutions Market

• 9.1. China Real World Evidence Solutions Market Overview
• 9.2. China Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Real World Evidence Solutions Market

• 10.1. India Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Real World Evidence Solutions Market

• 11.1. Japan Real World Evidence Solutions Market Overview
• 11.2. Japan Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Real World Evidence Solutions Market

• 12.1. Australia Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Real World Evidence Solutions Market

• 13.1. Indonesia Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Real World Evidence Solutions Market

• 14.1. South Korea Real World Evidence Solutions Market Overview
• 14.2. South Korea Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Real World Evidence Solutions Market

• 15.1. Western Europe Real World Evidence Solutions Market Overview
• 15.2. Western Europe Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Real World Evidence Solutions Market

• 16.1. UK Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Real World Evidence Solutions Market

• 17.1. Germany Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Real World Evidence Solutions Market

• 18.1. France Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Real World Evidence Solutions Market

• 19.1. Italy Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Real World Evidence Solutions Market

• 20.1. Spain Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Real World Evidence Solutions Market

• 21.1. Eastern Europe Real World Evidence Solutions Market Overview
• 21.2. Eastern Europe Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Real World Evidence Solutions Market

• 22.1. Russia Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Real World Evidence Solutions Market

• 23.1. North America Real World Evidence Solutions Market Overview
• 23.2. North America Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Real World Evidence Solutions Market

• 24.1. USA Real World Evidence Solutions Market Overview
• 24.2. USA Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Real World Evidence Solutions Market

• 25.1. Canada Real World Evidence Solutions Market Overview
• 25.2. Canada Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Real World Evidence Solutions Market

• 26.1. South America Real World Evidence Solutions Market Overview
• 26.2. South America Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Real World Evidence Solutions Market

• 27.1. Brazil Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Real World Evidence Solutions Market

• 28.1. Middle East Real World Evidence Solutions Market Overview
• 28.2. Middle East Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Real World Evidence Solutions Market

• 29.1. Africa Real World Evidence Solutions Market Overview
• 29.2. Africa Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Real World Evidence Solutions Market Competitive Landscape And Company Profiles

• 30.1. Real World Evidence Solutions Market Competitive Landscape
• 30.2. Real World Evidence Solutions Market Company Profiles
  • 30.2.1. Anthem Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Cegedim Health Data Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Clarivate PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Clinigen Group Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Cognizant Technology Solutions Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Real World Evidence Solutions Market Other Major And Innovative Companies

• 31.1. Flatiron Health Inc.
• 31.2. International Business Machines Corporation
• 31.3. ICON plc
• 31.4. IQVIA Holdings Inc.
• 31.5. Medpace Holdings Inc.
• 31.6. Optum Inc.
• 31.7. Oracle Corporation
• 31.8. PAREXEL International Corporation
• 31.9. PerkinElmer Inc.
• 31.10. PPD Inc.
• 31.11. SAS Institute Inc.
• 31.12. Syneos Health
• 31.13. Symphony Innovation LLC
• 31.14. UnitedHealth Group Incorporated
• 31.15. Amerisource Bergen Corporation

32. Global Real World Evidence Solutions Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Real World Evidence Solutions Market

34. Recent Developments In The Real World Evidence Solutions Market

35. Real World Evidence Solutions Market High Potential Countries, Segments and Strategies

• 35.1 Real World Evidence Solutions Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Real World Evidence Solutions Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Real World Evidence Solutions Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer